Institutional Sign In

Go

Pfizer Czech Republic - Net Debt Growth

Created with Highcharts 6.0.4%200320042005200620072008200920102011201220132014201520162017-7k-6k-5k-4k-3k-2k-1k01k2k

Pfizer CR`s Net Debt Growth reached -5,891 % in 2017. This is 15764 % less than in the previous year.

$1.99

Buy Net Debt Growth data for Pfizer Czech Republic.

$19.99

Buy all data for Pfizer Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
CompanyUnit
Amgen Czech Republic %
Bayer Czech Republic %
GlaxoSmithKline Czech Republic %
Merck Czech Republic %
Novartis Czech Republic %
Pfizer Czech Republic %
Roche Czech Republic %
Sanofi-Aventis Czech Republic %
Servier Czech Republic %
Walmark %
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
... ... ... ... ...           ... ... ... -17,482 83.3    
... ... ...               -71.1 -78.0 -272 13.5 595    
... ... ...               -18.8 76.2 33.3 -100 266,920    
... ...                 13.5 -7.53 18.5 -86.2 -113    
                    141 -75.5 -109 -2,141 -102    
... ...                 -703 -113 -72.3 1,069 -98.5    
... ... ...               -100 -40,192 88.9 90.0 21.9   ...
... ... ... ...             -4.00 14.4 -34.2 -46.3 -14.4    
... ... ... ... ... ... ... ... ... ... ... ... 41.6 -14.0 -44.7    
... ... ...               -41.2 340 -22.8 -12.0 166